Samsung Biologics Secures Landmark $1.24 Billion Contract with Asia-Based Pharma

INCHEON, South Korea, Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), announced a contra...

October 22, 2024 | Tuesday | News
Sanofi and CD&R Announce Exclusive Negotiations for 50% Stake in Opella, Poised to Create Global Consumer Healthcare Leader

 Sanofi and CD&R announce a plan to join forces to fuel Opella’s ambitions as a French-headquartered, global consumer healthcare champion. S...

October 22, 2024 | Tuesday | News
Foresee Pharmaceuticals Completes Phase 1 Trial of Linvemastat, a Promising Oral MMP-12 Inhibitor for Respiratory and IBD Conditions

Foresee Pharmaceuticals (TPEx: 6576), ("Foresee") announced the successful completion of its Phase 1 single and multiple ascending dose (SAD/MAD) clinical ...

October 21, 2024 | Monday | News
Amicus Therapeutics and Teva Pharmaceuticals Reach License Agreement on GALAFOLD®

Amicus Therapeutics (Nasdaq: FOLD) announced that it has entered into a License Agreement (Agreement) with Teva Pharmaceuticals USA, Inc. and Teva Pharmace...

October 18, 2024 | Friday | News
Symbiosis Expands with £1.2M Barclays-Financed Acquisition of New 20,000 Sq/Ft Stirling Facility to Boost High-Tech Medicine Production

    Symbiosis acquires a 20,000 sq/ft building in Stirling, UK, to house new high-tech medicines manufacturing capacity, financed by £1...

October 09, 2024 | Wednesday | News
A*STAR and Flagship Pioneering Partner to Drive Breakthrough Innovation in Health and Sustainability with SGD100 Million Investment

Organizations Plan to Jointly Advance Breakthrough Solutions in Human Health and Sustainability, Drive Research Collaboration, Entrepreneurship and Acceler...

October 03, 2024 | Thursday | News
Thermo Fisher Scientific Expands OSD Capabilities with $22 Million Investment to Accelerate Drug Development

To provide flexible and innovative solutions for early development challenges commonly faced by biotech and pharmaceutical companies, Thermo Fisher Scien...

September 27, 2024 | Friday | News
Novo Holdings Invests £50M in Oxford Nanopore Technologies, Pioneers of Advanced DNA/RNA Sequencing

Investment in Oxford Nanopore, innovators of a transformational new generation of sensing technology that today specialises in DNA/RNA sequencing &pou...

August 01, 2024 | Thursday | News
Charles River Partners with Autobahn Labs to Accelerate Academic Drug Discovery and Development

Agreement establishes Charles River as the preferred partner for Autobahn Labs, leveraging drug discovery and development capabilities to acceler...

July 25, 2024 | Thursday | News
Rona Therapeutics Secures $35 Million Series A+ Financing Led by LongRiver Investments

Rona Therapeutics, a clinical stage pioneering platform company in nucleic acid drug research and development, today announced the completion of $35 Mill...

July 19, 2024 | Friday | News
CordenPharma Announces Record €900M Investment to Expand Peptide Platform in US and Europe

CordenPharma is making a record investment of ~€900m over the next 3 years in expanding its peptide platform, both at its Colorado, US site and in...

July 16, 2024 | Tuesday | News
AusperBio Therapeutics Secures $37 Million Series A Financing

AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (collectively AusperBio), a privately held clinical-stage biotechnology company dedicated to ...

July 15, 2024 | Monday | News
Apriori Bio Secures $1.1 Million from CEPI to Enhance AI-Driven Vaccine Platform Against Evolving Viruses

Biotechnology company Apriori Bio has been awarded US $1.1 million from CEPI to advance its biology-informed artificial intelligence platform Octavi...

July 09, 2024 | Tuesday | News
Adcytherix Launches with €30 Million Seed Funding to Pioneer Next-Generation Antibody-Drug Conjugates for Cancer Treatment

Vision is to establish a leading ADC developer to treat high unmet need diseases such as cancer. Founded by the team that founded and sold Emergence T...

June 11, 2024 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close